ArticleThe open respiratory medicine journal2022

Real-World Safety and Efficacy of Glycopyrronium Bromide in Japanese Patients with COPD: A 52-Week Post-Marketing Surveillance.

Chihiro Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.